Health Condition 1: D058- Other specified type of carcinomain situ of breast
Conditions
Interventions
Intervention1: Counselling: No treatment is planned.
Intervention is only in the form of "counselling" only in the second (prospective) phase, wherein the counselling will be carried out 4 times at 6
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with histologically confirmed non-metastatic breast cancer 2) Hormone receptor (HR) positive (defined as at-least 1% cells positive for either ER or PR or both) and 3) Who will be attending the breast OPDâ??s of any discipline during the study period irrespective of their registration date to Tata Memorial Centre. 4) Patients on treatment with endocrine therapy who had completed at least 6 months of treatment (this corresponds to one prescription fill).
Exclusion criteria
Exclusion criteria: 1) Non-Indianpatients 2) Metastatic disease 3) Not received cancer-directed surgery 4) Those patients who have not completed at-least 6 months of endocrine therapy 5) Had experienced recurrence prior to the 2-year follow-up survey (For only prospective cohort)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the compliance to oral endocrine therapy in non-metastatic breast cancer patients on adjuvant endocrine therapy. Timepoint: 1) Retrospective Cohort Patients in the retrospective group will be assessed only once via the direct questionnaire and/or telephonic contact at a single time point (after completion of minimum 6 months of endocrine therapy). 2) Prospective cohort Patients in the prospective cohort will be assessed at 5 different time points, i.e., initially at the time of enrollment into the study and subsequently at every 6 months for a total period of 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess factors associated with non-adherence to treatment.Timepoint: 1) Retrospective Cohort Patients in the retrospective group will be assessed only once via the direct questionnaire and/or telephonic contact at a single time point(after completion of minimum 6 months of endocrine therapy). 2) Prospective cohort Patients in the prospective cohort will be assessed at 5 different time points, i.e., initially at the time of enrollment into the study and subsequently at every 6 months for a total period of 2 years | — |
Countries
India
Contacts
Public ContactDr Jyoti Bajpai
Tata Memorial Center
Outcome results
None listed